Sagimet Biosciences Inc. (SGMT) Revenue History
Annual and quarterly revenue from 2019 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
SGMT Revenue Growth
SGMT Revenue Analysis (2019–2025)
As of May 8, 2026, Sagimet Biosciences Inc. (SGMT) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.
Looking at the longer-term picture, SGMT's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $2.0 million in 2023.
When compared to Healthcare sector peers including MDGL (+256.8% YoY), AKBA (+25.7% YoY), and HALO (+37.6% YoY). Compare SGMT vs MDGL →
SGMT Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SGMTCurrent | $0 | - | - | - | |
 MDGL | $958M | +256.8% | - | -31.3% | |
 AKBA | $236M | +25.7% | -4.3% | 9.9% | |
 HALO | $1.4B | +37.6% | +39.2% | 58.4% | |
 ACAD | $1.1B | +9.9% | +19.4% | 9.8% | |
 GNFT | $67M | +9.8% | +16.8% | 4.9% |
SGMT Historical Revenue Data (2019–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-56,889,000 | - |
| 2024 | $0 | -100.0% | $0 | - | $-54,454,000 | - |
| 2023 | $2.0M | - | $2.0M | 100.0% | $-30,740,000 | -1537.0% |
| 2022 | $0 | - | $0 | - | $-31,055,000 | - |
| 2021 | $0 | - | $0 | - | $-23,719,000 | - |
| 2020 | $0 | - | $0 | - | $-11,400,000 | - |
| 2019 | $0 | - | $-88,000 | - | $-14,159,000 | - |
See SGMT's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SGMT Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SGMT vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSGMT — Frequently Asked Questions
Quick answers to the most common questions about buying SGMT stock.
Is SGMT's revenue growth accelerating or slowing?
SGMT TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is SGMT's long-term revenue growth rate?
Sagimet Biosciences Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is SGMT's revenue distributed by segment?
SGMT reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2019-2025 are available for download. Segment mix reveals concentration and diversification trends.